Immunovia AB (publ) (LON: 0G8X)
London
· Delayed Price · Currency is GBP · Price in SEK
0.489
-0.023 (-4.49%)
Jan 21, 2025, 8:07 AM BST
Immunovia AB Market Cap
Immunovia AB has a market cap or net worth of 5.85 million as of January 23, 2025. Its market cap has decreased by -23.87% in one year.
Market Cap
5.85M
Enterprise Value
1.96M
Revenue
46.49K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.49
Market Cap Chart
Since December 1, 2015, Immunovia AB's market cap has decreased from 32.41M to 5.85M, a decrease of -81.96%. That is a compound annual growth rate of -17.07%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 171.37B |
GSK plc | 55.43B |
Haleon | 33.25B |
Smith & Nephew | 9.04B |
ConvaTec Group | 4.92B |
Hikma Pharmaceuticals | 4.68B |
HUTCHMED (China) | 1.94B |
Oxford Nanopore Technologies | 1.48B |